Mindstate Design Labs has filed a notice of an exempt offering of securities to raise $15,103,934.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Mindstate Design Labs is raising up to $15,103,934.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.
About Mindstate Design Labs
Preclinical-stage biotechnology company developing the next generation of psychedelic-inspired therapeutics. The acute subjective experience of an altered conscious state is central to treatment outcomes. Solving the central problem in psychedelic drug development. There is no translational model to distinguish among different altered states of consciousness. Designing states of consciousness We’re mapping the biological basis of the varieties of psychedelic experience to enable precision design of modified conscious states. Osmanthus is a target discovery and phenotypic screening platform for altered conscious states. We’ve combined natural history, natural language processing, and biochemical data to build a predictive model for the precision design of modified conscious states. Our pipeline is based on a combination approach that uses psychedelic “primer” compounds together with non-psychedelic “probe” compounds that modulate the altered state of consciousness produced by the primer.
To learn more about Mindstate Design Labs, visit http://www.mindstate.design/
Mindstate Design Labs Linkedin Page: https://www.linkedin.com/company/mindstate-design-labs/
Contact:
Dillan DiNardo, Chief Executive Officer
415-548-4321
https://www.linkedin.com/in/dillandinardo/
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.